124 related articles for article (PubMed ID: 1919658)
21. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
[TBL] [Abstract][Full Text] [Related]
22. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Link MP; Shuster JJ; Donaldson SS; Berard CW; Murphy SB
N Engl J Med; 1997 Oct; 337(18):1259-66. PubMed ID: 9345074
[TBL] [Abstract][Full Text] [Related]
23. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology].
Tominaga S; Kondo M
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551
[No Abstract] [Full Text] [Related]
24. [Current technologies in radiotherapy for non-Hodgkin lymphomas].
Vinogradova IuN
Vopr Onkol; 2013; 59(4):509-12. PubMed ID: 24032229
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide].
Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M
Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
27. VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
Yalçin S; Kars A; Ozişik Y; Tekuzman G; Ozyilkan O; Celik I; Barişta I; Güllü I; Güler N; Baltali E; Firat D
Eur J Haematol; 1998 Oct; 61(4):261-5. PubMed ID: 9820633
[TBL] [Abstract][Full Text] [Related]
28. Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial.
Christie D; Dear K; Le T; Barton M; Wirth A; Porter D; Roos D; Pratt G
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1164-70. PubMed ID: 20638196
[TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
Yahalom J; Varsos G; Fuks Z; Myers J; Clarkson BD; Straus DJ
Cancer; 1993 Apr; 71(7):2342-50. PubMed ID: 8453557
[TBL] [Abstract][Full Text] [Related]
31. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
[TBL] [Abstract][Full Text] [Related]
32. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
33. [Radiotherapy indications in non-Hodgkin lymphoma].
Quero L; Hennequin C; Brice P
Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
[TBL] [Abstract][Full Text] [Related]
34. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases.
Heyning FH; Hogendoorn PC; Kramer MH; Hermans J; Kluin-Nelemans JC; Noordijk EM; Kluin PM
Leukemia; 1999 Dec; 13(12):2094-8. PubMed ID: 10602434
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
36. [The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
Sotnikov VM; Pan'shin GA; Pivnik AV; Grigor'eva MA
Ter Arkh; 1992; 64(7):54-6. PubMed ID: 1440370
[No Abstract] [Full Text] [Related]
37. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
38. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Decaudin D
N Engl J Med; 1998 Nov; 339(20):1477. PubMed ID: 9841321
[No Abstract] [Full Text] [Related]
39. Progress in treatment of advanced non-Hodgkin's lymphoma in children--report on behalf of the Polish Children's Leukemia/Lymphoma Study Group.
Bogusławska-Jaworska J; Rodziewicz B; Kazanowska B; Armata J; Cyklis R; Daszkiewicz P; Dłuzniewska A; Matysiak M; Ochocka M; Radwańska U
Haematol Blood Transfus; 1987; 31():39-42. PubMed ID: 3327778
[No Abstract] [Full Text] [Related]
40. Successful treatment of primary gastric non-Hodgkin's lymphoma with chemotherapy and radiotherapy.
Tsukada K; Arima K; Ohosone Y; Hanada T; Mita S; Harada K; Matsuoka Y; Irimajiti S; Fukuda J
Intern Med; 1992 Mar; 31(3):368-72. PubMed ID: 1377061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]